Wildcat Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
+$4.24M |
| 2 |
PLYA
Playa Hotels & Resorts
PLYA
|
+$3.16M |
| 3 |
SBR
Sabine Royalty Trust
SBR
|
+$2.78M |
| 4 |
UNIT
Uniti Group
UNIT
|
+$2.59M |
| 5 |
Alibaba
BABA
|
+$2.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MiMedx Group
MDXG
|
+$14.4M |
| 2 |
ImmunityBio
IBRX
|
+$4.73M |
| 3 |
CoStar Group
CSGP
|
+$2.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 14.49% |
| 2 | Healthcare | 7.69% |
| 3 | Financials | 2.34% |
| 4 | Consumer Discretionary | 1.7% |
| 5 | Energy | 0.76% |
Similar funds
Wildcat Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Wildcat Capital Management held 22 positions worth $376M, up 19% from $316M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Wildcat Capital Management withdrew a net $25.4M in Q2 2017, closing 4 positions and reducing 2 holdings. Its most notable exit was MiMedx Group, an estimated $14.4M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wildcat Capital Management opened a new position in Playa Hotels & Resorts worth $3.58M.
- Wildcat Capital Management's largest Q2 2017 buy was Playa Hotels & Resorts: 300,000 shares worth $3.58M.
- Wildcat Capital Management added most to Kite Pharma, Inc. in Q2 2017, an estimated $4.24M increase.
- Wildcat Capital Management's biggest Q2 2017 reduction was ImmunityBio, cutting an estimated $4.73M.
- Wildcat Capital Management fully exited MiMedx Group in Q2 2017, selling an estimated $14.4M.
- Wildcat Capital Management's ten largest holdings make up 97% of its $376M portfolio in Q2 2017.
- Wildcat Capital Management opened 7 new positions and closed 4 in Q2 2017.
- Wildcat Capital Management's portfolio value rose 19% quarter-over-quarter to $376M.
Based on Wildcat Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.